TMO
賽默飛世爾 THERMO FISHER SCIENTIFIC INC.
+6.16 (+0.95%)654.59USD1.3M成交股數242B市值35.2本益比(近四季)5.2股價營收比+10.5%營收年增(近四季)2026-10-21下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 12.0B+10% | 11.0B+6% | 12.2B+15% | 11.1B+6% | 10.9B+5% | 10.4B-5% | 10.6B+0% | 10.5B-1% | 10.3B | 10.9B | 10.6B | 10.7B |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 364M | 336M | 357M | 346M | 352M | 342M | 346M | 339M | 331M | 327M | 319M | 345M |
| 銷售管理費用 | 2.3B | 2.2B | 2.4B | 2.2B | 2.1B | 2.1B | 2.1B | 2.1B | 2.2B | 2.1B | 2.0B | 2.1B |
| 營業利益 | 2.1B+14% | 1.9B+9% | 2.3B+23% | 1.9B+7% | 1.8B+10% | 1.7B-7% | 1.8B-1% | 1.8B+15% | 1.7B | 1.9B | 1.9B | 1.6B |
| 營業利益率 | 17.4% | 16.9% | 18.5% | 17.5% | 16.9% | 16.6% | 17.3% | 17.3% | 16.1% | 17.0% | 17.6% | 14.8% |
| 稅後淨利 | 1.7B+7% | 1.7B+10% | 2.0B+22% | 1.6B+4% | 1.6B+21% | 1.5B-6% | 1.6B-4% | 1.5B+14% | 1.3B | 1.6B | 1.7B | 1.4B |
| 淨利率 | 14.5% | 15.0% | 16.2% | 14.5% | 14.9% | 14.5% | 15.4% | 14.7% | 12.9% | 14.8% | 16.0% | 12.7% |
| 稀釋 EPS | 4.68+9% | 4.43+11% | 5.21+23% | 4.27+6% | 4.28+24% | 3.98-5% | 4.25-4% | 4.04+15% | 3.46 | 4.20 | 4.42 | 3.51 |
| 稀釋股數 | 371M | 373M | 378M | 378M | 378M | 379M | 384M | 383M | 384M | 388M | 388M | 388M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.1B | 3.3B | 9.9B | 2.0B | 4.6B | 4.1B | 4.6B | 7.1B | 5.5B | 8.1B | 6.2B | 3.1B |
| 應收帳款 | 9.5B | 9.2B | 8.9B | 8.9B | 8.6B | 8.5B | 8.3B | 7.9B | 7.9B | 8.2B | 8.4B | 8.0B |
| 存貨 | 5.6B | 5.5B | 5.4B | 5.7B | 5.6B | 5.2B | 5.4B | 5.2B | 5.1B | 5.1B | 5.4B | 5.7B |
| 總資產 | 113B | 113B | 110B | 103B | 101B | 99.0B | 100B | 98.5B | 97.1B | 98.7B | 97.1B | 94.1B |
| 有息負債 | 42.3B | 42.9B | 39.2B | 35.5B | 35.0B | 34.0B | 35.1B | 35.2B | 35.4B | 34.7B | 35.1B | 33.8B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 52.7B | 51.9B | 53.4B | 51.0B | 50.5B | 49.4B | 49.0B | 47.4B | 45.5B | 46.7B | 45.3B | 43.8B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −38.2B | −39.7B | −29.3B | −33.5B | −30.5B | −29.9B | −30.5B | −28.1B | −29.9B | −26.7B | −28.9B | −30.7B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 1.2B+65% | – | – | – | 723M | – | – | 1.3B | – | – | – |
| 資本支出 | – | 376M | – | – | – | 362M | – | – | 347M | – | – | – |
| 自由現金流 | – | 816M+126% | – | – | – | 361M | – | – | 904M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | 3.0B | – | – | – | 2.0B | – | – | 3.0B | – | – | – |
| 現金股利 | – | 162M | – | – | – | 149M | – | – | 135M | – | – | – |
| 自由現金流率 | – | 7.4% | – | – | – | 3.5% | – | – | 8.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 44.8B
| Laboratory Products And Biopharma Services | 23.8B | 53.1% | +3.5% |
|---|---|---|---|
| Life Sciences Solutions | 8.8B | 19.6% | +7.6% |
| Analytical Instruments | 7.6B | 16.9% | +3.9% |
| Specialty Diagnostics | 4.7B | 10.4% | +5.1% |
地區2025 年度 · 89.1B
| North America | 23.0B | 25.8% | +2.4% |
|---|---|---|---|
| 美國以外 | 22.3B | 25.0% | +5.6% |
| 美國 | 22.2B | 25.0% | +2.2% |
| 歐洲 | 11.8B | 13.3% | +8.9% |
| 亞太 | 8.1B | 9.1% | +1.8% |
| Other Regions | 1.6B | 1.8% | +2.3% |
產品／服務2025 年度 · 44.6B
| Consumables | 18.7B | 41.9% | +6.1% |
|---|---|---|---|
| 服務 | 18.6B | 41.7% | +4.2% |
| Instruments | 7.3B | 16.4% | -1.9% |
| 產品 小計 | 26.0B | 58.3% | +3.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 44.6B | +3.9% | 6.7B | 15.1% | 17.74 | 6.3B |
| FY2024 | 42.9B | +0.1% | 6.3B | 14.8% | 16.53 | 7.3B |
| FY2023 | 42.9B | -4.6% | 6.0B | 13.9% | 15.45 | 6.9B |
| FY2022 | 44.9B | +14.5% | 7.0B | 15.5% | 17.63 | 6.9B |
| FY2021 | 39.2B | +21.7% | 7.7B | 19.7% | 19.46 | 6.8B |
| FY2020 | 32.2B | +26.1% | 6.4B | 19.8% | 15.96 | 6.8B |
| FY2019 | 25.5B | +4.9% | 3.7B | 14.5% | 9.17 | 4.0B |
| FY2018 | 24.4B | – | 2.9B | 12.1% | 7.24 | 3.8B |